The value as a thyroid function test of a new, rapid, and highly sensitive immunoradiometric assay for thyroid stimulating hormone (TSH) was assessed in 188 consecutive new patients with suspected hyperthyroidism. The diagnosis was made on clinical grounds and on the basis of serum total triiodothyronine and thyroxine concentrations and the response of TSH to thyrotrophin releasing hormone (TRH) as measured by radioimmunoassay. In all except one patient the basal TSH concentration by immunoradiometric assay predicted the response of TSH by radioimmunoassay to TRH, an undetectable value being recorded in patients with a
condition improved after treatment with amoxycillin, physiotherapy, and blood transfusion. At this time a 10%o reticulocytosis developed; the peripheral lymphocyte numbers including OKT4 reactive cells were extremely low. In view of the considerable risk of opportunistic infection and the steroid myopathy the dose of prednisolone was reduced to 15 mg. From that time his condition improved appreciably. No further blood transfusion was required, and in October 1983 the dose of prednisolone was reduced to 10 mg. He subsequently remained in remission taking cyclophosphamide 50 mg plus prednisolone 10 mg a day.
Discussion
Idiopathic acquired pure red cell aplasia is associated with thymoma in about one third to one half of cases. Its occurrence with other autoimmune disorders and reports of successful responses to thymectomy, immunosuppressive drugs, and plasmapheresis3 have suggested an immunological basis. In some cases the suppression of erythropoiesis appears to be mediated by humoral agents, thought to be antibodies. Putative antibodies have been shown against erythropoietin and mature erythroblasts.3 Recent reports have shown that inhibition of erythropoiesis can be effected by suppressor T lymphocytes.' 2 Monoclonal antibodies are available to identify T cell subsets.4 The T8 positive population contains both suppressors and cytotoxic cells. Our patient had an excess of lymphocytes in his bone marrow and high numbers of T8 positive cells in peripheral blood before treatment. Thymectomy followed by immunosuppression with prednisolone and cyclophosphamide effected a considerable reduction in T8 positive cells and clinical remission. Although functional studies were not performed, we think it probable that these cells played a part in the suppression of erythropoiesis.
Bacigalupo et al indicated that in severe aplastic anaemia the detection of suppressor T cells in the bone marrow correlates with successful responses to immunosuppressive regimens.-5 Our observation would lend support to a similar assertion regarding pure red cell aplasia.
response and a measurable value in those with a normal test result. This clear relation was not observed for basal TSH concentrations as measured by radioimmunoassay. In a series of 39 hospital inpatients with acute or chronic non-thyroidal illness, of whom 11 had low concentrations of total thyroxine or triiodothyronine, or both, basal TSH concentrations were detectable by both radioimmunoassay and immunoradiometric assay in all cases and were associated with normal responses to TRH.
The immunoradiometric assay for TSH, which is commercially available, may therefore obviate the need for the more time consuming TRH test and simplify the approach to thyroid function testing in patients with suspected hyperthyroidism. luteinising hormone at postmenopausal concentrations, as shown by basal TSH concentrations that were consistently undetectable in both premenopausal and postmenopausal patients with thyrotoxicosis. This was in agreement with the kit manufacturer's claim of cross reactivities of less than 0 0020,, for both follicle stimulating hormone and luteinising hormone. tMean value from sample replicates.
$Mean value for serum pools 3 0, 7-1, 21-0, and 52 0 mU/1.
Patients and methods
We studied 188 new patients consecutively referred to a thyroid clinic with suspected hyperthyroidism. Their mean age was 48 (range 19-81). Thyroid state was assessed clinically by one of us (ADT) and by measurement of serum concentrations of total triiodothyronine, total thyroxine, and TSH (by radioimmunoassay) before and 20 minutes after intravenous administration of 200 plg TRH (TRH test). Basal TSH concentrations were also measured by the immunoradiometric assay, but the results were not used to determine the diagnostic categories of the patients. In 110 patients there was evidence of hyperthyroidism with raised serum concentrations of total triiodothyronine and thyroxine and a subnormal TSH response to TRH. The hyperthyroidism was due to Graves' disease, multinodular goitre, and solitary autonomously functioning thyroid nodule in 87, 20, and three patients respectively. Sixteen patients were considered to have subclinical hyperthyroidism on the basis of normal thyroid hormone concentrations and a subnormal TSH response to TRH.
Ten of these patients had a multinodular goitre, one a solitary thyroid nodule that resolved spontaneously, two ophthalmic Graves' disease, and three diffuse thyroid enlargement presumed to represent Graves' disease in remission. Of the remaining 62 euthyroid patients, 13 had a solitary thyroid nodule, 14 a multinodular goitre, and 35 no evidence of thyroid disease. In these 62 patients normal concentrations of total triiodothyronine and thyroxine were associated with a normal TRH test result.
The above thyroid function tests were also performed within 36 hours after admission in 39 patients admitted consecutively as an emergency to a general medical unit with acute or chronic nonthyroidal illness. Their mean age was 61 (range 15-86), and none had clinical evidence or a history of thyroid disease.
After collection of blood the separated serum was stored at -20°C in aliquots for each assay. Serum total triiodothyronine and thyroxine concentrations were measured by double antibody radioimmunoassays,' the normal ranges being 1-1-2 8 nmol/l (0-7-1 8 ng/ml) and 70-150 nmol/1 (5-4-11-7 pg/100 ml) respectively. Serum TSH concentration was measured by the double antibody radioimmunoassay routinely used in the laboratory,2 the normal range being from undetectable to 6 mU/l. The assay used a sheep anti-TSH antiserum of good specificity such that there was no interference from follicle stimulating hormone and luteinising hormone at postmenopausal concentrations, or from human chorionic gonadotrophin at the concentrations found in pregnancy.
TSH was also measured by the Boots-Celltech Sucrosep TSH immunoradiometric assay using the protocol enclosed with the kit.
Both the radioimmunoassav and the immunoradiometric assay were calibrated in terms of the TSH International Reference Preparation 68/38. The immunoradiometric assay had a substantially lower limit of detection, wider working range, and better within assay precision than the radioimmunoassay (table I). Although our radioimmunoassay has a lower limit of detection than many others, this is achieved only at the expense of a relatively long assay time. There was an excellent correlation between TSH concentrations measured by radioimmunoassay and by immunoradiometric assay in a separate series of 108 patients in whom values lay between 0Q9 and 130 mU/l (r---0 99; p<0 001). There was no evidence of interference in the immunoradiometric assay from follicle stimulating hormone and
Results
The figure shows basal TSH concentrations measured by both radioimmunoassay and immunoradiometric assay in the patients attending the clinic and in those with non-thyroidal illness. Among the 110 patients with hyperthyroidism TSH was undetectable by radioimmunoassay (less than 0 9 mU/l) in 101, and in the nine remaining patients concentrations of 10-1 7 mU/1 were recorded, which overlapped the euthyroid range. In contrast, the more sensitive immunoradiometric assay recorded undetectable concentrations (less than 0-07 mU/l) in all patients. Among the 16 patients with subclinical hyperthyroidism radioimmunoassay recorded undetectable TSH concentrations in 13 and concentrations of 1 1, 10, and 10 mU/l in three; whereas immunoradiometric assay recorded undetectable concentrations in all but one patient, in whom a value of 0-14 mU/l was recorded (see Discussion). TSH concentrations were detectable in 60 of the 62 euthyroid patients and in all 39 with non-thyroidal illness when measured by radioimmunoassay, and in every patient in these two groups when measured by immunoradiometric assay.
Comparison of basal TSH concentrations with the response of TSH to TRH measured by radioimmunoassay (table II) showed that all but one patient with a detectable basal TSH concentration on immunoradiometric assay yielded a normal result to the TRH test. Conversely, in all patients with an undetectable basal TSH concentration on immunoradiometric assay there was a subnormal response of TSH to TRH on radioimmunoassay. The same close relation was not seen, however, between basal TSH concentrations measured by radioimmunoassay and the result of the TRH test. Thus two euthyroid patients with undetectable TSH concentrations on radioimmunoassay gave normal responses to TRH, and nine hyperthyroid patients and three patients with subclinical hyperthyroidism with detectable TSH concentrations on radioimmunoassay showed a subnormal response to TRH. In all 39 patients with non-thyroidal illness there were detectable TSH concentrations on radioimmunoassay and immunoradiometric assay associated with normal TRH test results, despite low concentrations of total thyroxine or triiodothyronine, or both, in 11.
Discussion
The important advantages of the immunoradiometric assay compared with the radioimmunoassay-namely, higher specificity, lower limit of detection, wider working range, and speed of analysis-are a consequence of the fundamentally different principles on which the assays are based. The BootsCelltech Sucrosep immunoradiometric assay uses a combination of two monoclonal antibodies, each of which is specific for a different epitope on the TSH molecule. One antibody is bound to a solid matrix while the other is radiolabelled. Simultaneous binding of both antibodies to TSH results in the formation of a radiolabelled insoluble "sandwich," the concentration of which is directly related to the amount of TSH in the sample. The concentration of the insoluble sandwich is indicated by the amount of radiolabel in the insoluble form. The specificity derives from the requirement for binding by two distinctly separate antibodies, while the other advantages of low limit of detection, wide working range, and speed derive from the use of excess reagents in the assay.
Although the immunoradiometric assay is superior to the radioimmunoassay from the laboratory point of view, it is important to assess whether these analytical advantages provide real improvements for the investigation of thyroid disease. Our results show that TSH concentrations as measured by the immunoradiometric assay can reliably predict the response to TRH and thereby simplify the assessment of thyroid function in patients with suspected hyperthyroidism. Whereas basal TSH concentration as measured by radioimmunoassay predicted the response of TSH to TRH in 175 out of 188 patients, when measured by immunoradiometric assay it predicted the response in. 187 of the 188 patients. The exception was a patient who presented with a solitary thyroid nodule that regressed spontaneously after three months, suggesting a diagnosis of haemorrhage into a cyst or adenoma. At presentation total triiodothyronine and thyroxine concentrations were in the middle of their respective normal ranges at 1 6 nmol/l (1-0 ng/ml) and 91 nmol/l (7-1 tg/100 ml). The basal TSH concentration on radioimmunoassay was 10 mU/l and showed a marginally subnormal increase to 19 mU/l after administration of TRH. Such a result was not expected on clinical grounds, and the basal TSH concentration of 0 14 mU/l as measured by immunoradiometric assay was more consistent with the probable diagnosis.
Our Immunoradiometric assays are now increasingly being used to measure peptide hormones. Although these new methods are known to have several analytical advantages over radioimmunoassay, we believe that this study is the first to show an appreciable clinical benefit from the new generation of immunoassay technology.
ONE HUNDRED YEARS AGO
The class of idiots commonly known as "Shah Dowla's mice," from the peculiar mouse-like conformation of their cranium, have their headquarters at a shrine in the Gujerat district of the Punjab. Their appearance is very characteristic-projecting mouth, extremely low forehead, and cranium long drawn out and tapering to the vertex. It is generally believed that this malformation is produced by forcible moulding or compression of the head in infancy. In 
